A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
An animal model of acquired hypoparathyroidism (HypoPT) is crucial to understanding how HypoPT affects mineral ion homeostasis and to verify the effectiveness of novel treatments. Here, a technique is presented to generate an acquired hypoparathyroidism (AHypoPT) rat model by parathyroidectomy (PTX) using carbon nanoparticles.
Hypoparathyroidism (HypoPT) is a rare disease involving the parathyroid glands that is characterized by a reduced secretion or potency of the parathyroid hormone (PTH), which leads to high serum phosphorus levels and low serum calcium levels. HypoPT most commonly results from accidental damage to the glands or their removal during thyroid or other anterior neck surgery. Parathyroid/thyroid surgery has become more common in recent years, with a corresponding rise in the occurrence of HypoPT as a postoperative complication. There is a critical need for a HypoPT animal model to better understand the mechanisms underlying the effects of HypoPT on mineral ion homeostasis and to verify the therapeutic effectiveness of novel treatments. Here, a technique is reported to create acquired HypoPT in male rats by performing parathyroidectomy (PTX) using carbon nanoparticles. The rat model shows great promise over the mouse models of hypoparathyroidism. Importantly, the human PTH receptor binding region has an 84.2% sequence similarity with that of the rat, which is higher than the 73.7% similarity shared with mice. Moreover, the effects of estrogen, which can affect the PTH/PTHrP receptor signaling pathway, have not been fully investigated in male rats. Carbon nanoparticles are lymphatic tracers that stain the thyroid lymph nodes black without affecting their function, but they do not stain the parathyroid glands, which makes them easy to identify and remove. In this study, serum PTH levels were undetectable after PTX, and this resulted in significant hypocalcemia and hyperphosphatemia. Thus, the clinical state of postoperative HypoPT can be remarkably represented in the rat model. Carbon-nanoparticle-assisted PTX can, therefore, serve as an extraordinarily effective and readily implementable model for studying the pathogenesis, treatment, and prognosis of HypoPT.
Parathyroid hormone (PTH) is secreted by the parathyroid glands. It is a major modulator of the calcium balance, maintains phosphate metabolism, and participates in bone turnover1,2. Hypoparathyroidism (HypoPT) manifests as a decreased secretion or functional loss of PTH. It is a rare endocrine disorder, with a prevalence of approximately 9-37 per 100,000 person-years3,4,5. HypoPT is characterized by decreased serum PTH and calcium levels accompanied by increased serum phosphorus6,
This study was approved by the Institutional Animal Care and Use Committee at the State Key Laboratory of Oral Diseases, Sichuan University. Permission was obtained from relevant local agencies before the experiment. Eight 8-10 week old male Sprague-Dawley (SD) rats, with an average weight of 200-250 g, were used for the present study. The animals were obtained from a commercial source (see Table of Materials). Food and water were provided ad libitum throughout the experimental period.
The locations and number of parathyroid glands were initially observed in rats under a dissection microscope. Before the carbon nanoparticle injection, the thyroid glands were a translucent red color, and the parathyroid glands were hardly distinguishable under the microscope (Figure 1A). After the nanoparticle injection, the thyroid glands were stained black, while the parathyroid glands remained unstained (Figure 1B). The careful dissection of the light-colore.......
Epidemiological reports indicate that the detection of thyroid diseases has increased significantly, and the number of related surgeries performed has increased accordingly19,20. The incidence rate of postsurgical hypoparathyroidism is approximately 7.6%8,21, while the increased morbidity of acquired hypoparathyroidism has caused this rare disease to gain greater research attention. It is, therefore, part.......
This work was supported by NSFC grant 81800928, Research Funding from the West China School/Hospital of Stomatology Sichuan University (No. RCDWJS2021-1), and the State Key Laboratory of Oral Diseases Open Funding grant SKLOD-R013.
....Name | Company | Catalog Number | Comments |
0.9% Sodium Chloride Solution | Kelun Co. Sichuan, China | ||
10 µL 30G NanoFil Syringe | WPI | ||
6-0 polyglactin 910 suture with needle | Ethicon, Inc | J510G | |
Calcium LiquiColor test | EKF | 0155-225 | For Ca2+ analysis |
Carbon Nanoparticles Suspension Injection | Lummy, Chongqing, China | H20073246 | 1 mL : 50 mg |
Creatinine (Cr) Assay kit ( sarcosine oxidase ) | Jiancheng, Nanjing, China | C011-2-1 | For creatinine analysis |
Disposable Scalpel | Shinva, China | ||
Dumstar Biology forceps | Shinva, China | ||
Micro Dissecting Spring Scissors | Shinva, China | ||
MicroVue Rat intact PTH ELISA | Immunotopics | 30-2531 | For the measurement of PTH in rat serum |
Needle Holder | Shinva, China | ||
Phosphorus Liqui-UV test | EKF | 0830-125 | For Pi analysis |
Ply gauze | Weian Co. Henan, China | ||
Povidone-Iodine | Yongan pharmaceutical Co.Ltd. Chengdu, China | ||
Prism 9.0 (statistics and graphing software) | GraphPad Software, Inc., San Diego, CA, USA | https://www.graphpad.com/scientific-software/prism/ | |
Rat C-telopeptide of type I collagen (CTX-I) ELISA Kit | CUSABIO, Wuhan, China | CSB-E12776r | For CTX-I analysis |
Rat Osteocalcin/Bone Gla Protein (OT/BGP) ELISA Kit | CUSABIO, Wuhan, China | CSB-E05129r | For osteocalcin analysis |
Safety Single Edge Razor Blades | American Safety Razor Company | 66-0089 | |
Sprague-Dawley Rats | 8 to 10 weeks old | ||
Surgical Incise Drapes | Liangyou Co. Sichuan, China | ||
Urea Assay Kit | Jiancheng, Nanjing, China | C013-2-1 | For urea analysis |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved